DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Thursday reported a loss of $12 million in its second quarter.

On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 89 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share.

Zynerba shares have decreased 49 percent since the beginning of the year. The stock has fallen 57 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE